Autopsy report · NCT00805740
An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Deep Tissue Infection Due To Candida
Cause of deathFunding or business, also safety
“The study was terminated prematurely on May 18, 2012 due to slow enrollment. The study was not terminated due to any safety issues or concerns.”
Life of this trial
- Registered 5 months before it started.
- Ran for about 3 years 2 months before it stopped.
- 41 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 3
- Sponsor
- Pfizer
- Sponsor type
- Industry
- Conditions
- Candidiasis; Fungemia
- Interventions
- Active anidulafungin; Active Caspofungin
- Participants
- 41
- Sites
- 18
- Countries
- Belgium, Bulgaria, Canada, Netherlands, Portugal, Romania, Russia, Switzerland, United States
Trials that died the same way
- Evaluation of the Clinical and Economic Impact of painPRIMER in the Treatment of Low Back Pain in a Primary Care Setting
“The study was terminated on 02-Jun-2014 due to slow enrollment. The study was not terminated for reasons of either safety or efficacy.” - Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate
“This study was prematurely terminated on June 25, 2014 due to lack of enrollment.” - Study to Evaluate the Efficacy and Safety of Moxifloxacin Versus Amoxicillin/Clavulanate in the Treatment of Acute Bacterial Rhinosinusitis
“The study was prematurely terminated due to slow enrollment beyond the planned study timelines.” - A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic Asthma
“Due to low enrollment, this study was terminated early.” - MIRACLE EF Clinical Study
“The study was terminated early due to low enrollment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.